- Telehealth Visits
- Insurance plan information
David Fischer, MD, PhD
Neurology- Telehealth Visits
- Insurance plan information
David Fischer, MD, PhD
Neurology- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Behavioral Neurology & Neuropsychiatry, United Council for Neurologic Subspecialties
- Neurology, American Board of Psychiatry/Neurology-Psychiatry
Fellowship
- Behavioral Neurology, University of CA at San Francisco - Neurology GME
Residency
- Neurology, University of Alabama School of Medicine - GME
Internship
- Neurology, University of Alabama School of Medicine - GME
Degree
- MD, Michigan State Univ - College of Human Medicine
My expertise
Specialties
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%224225%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%224225%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Showing 1-6 of 17 reviews
- October 22, 20255 out of 5 Stars
Dr. Fischer is very competent and kind, such a great combination!
- August 29, 20255 out of 5 Stars
Dr. Fischer was very professional and empathetic about all the questions I asked him. He gave me answers to each question. Also provided follow up on what I should do. I have total trust in his recommendations.
- August 8, 20255 out of 5 Stars
All my questions were answered in depth. I walked feeling very confident in his answers.
- June 6, 20255 out of 5 Stars
He's the best!
- May 25, 20255 out of 5 Stars
Thank you ever so much for getting me on a path that will improve my health!
- May 17, 20255 out of 5 Stars
Excellent
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.